• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Galen Institute

A not-for-profit health and tax policy research organization.

  • Home
  • About Us
    • Mission and History
    • Officers and Trustees
    • Scholars and Staff
    • Who was Galen?
  • Activities
    • Core Activities
    • State Leaders Calls
    • Commentary and Oped Tutorial
    • Our Book
    • Galen Guides
  • Donate
  • Contact Us
  • Major Papers
  • Broadcast Interviews
  • Health Policy Consensus Group

James Capretta: More Good News as the Medicare Drug Benefit Approaches Ten Years

POSTED BY Galen Institute on September 19, 2013.

As the political back and forth over Obamacare intensified this summer, it largely went overlooked that the Medicare prescription drug benefit continues to outperform expectations.  In July, the Department of Health and Human Services (HHS) announced that the average premium for the drug benefit in 2014 would be just $31.  That’s remarkable given that the average premium had held steady at $30 in the three previous years. HHS also announced that, because of very moderate spending growth in the program, the standard deductible would fall from $325 in 2013 to $310 in 2014.

Perhaps the reason that no one has taken much notice of this good news is because it has become so commonplace with the drug benefit.  In December, it will have been ten years since President George W. Bush signed the new benefit into law.  Very few federal programs have had such a successful first decade.

Continue Reading…

Filed Under: Uncategorized

Primary Sidebar

NEW – OF INTEREST

Health Care Choices 20/20:

A Vision for the Future


See the latest interview of Grace-Marie Turner on C-SPAN

SEARCH

LATEST NEWSLETTER ISSUES

SUBSCRIBE

Social Media

Like Us On Facebook

Twitter: @galeninstitute

 

Copyright Galen Institute, Inc © 2021; · Log in